Clinical Trial

Screening for Obstructive Respiratory Disorders in the General Population During the "Mai Poumon 2026" Prevention Campaign: Prevalence and Impact on the Care Pathway

Study acronym: Mai Poumons 26
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Undiagnosed COPD represents a significant issue in terms of morbidity and mortality, as nearly 50% of smokers with chronic respiratory symptoms also experience impaired quality of life and acute events similar to COPD exacerbations. We aim to study the prevalence of airflow obstruction (AO) and PRISm (preserved ratio impaired spirometry) in the general population.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-04.
Trial Details
NCT Number NCT07575880
Lead Sponsor Centre Hospitalier de la côte Basque
Conditions Chronic Obstructive Lung Disease, Airflow Obstruction
Enrollment 200 participants
Start Date 2026-05-09
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-13